E.Q. Wu

The CHOICE trial: adalimumab demonstrates safety, fistula healing, improved quality of life and increased work productivity in patients with Crohn’s disease who failed prior infliximab therapy

Simon Lichtiger, DG Binion, Douglas C. Wolf et al. · Alimentary Pharmacology & Therapeutics · 2010 · 186 citations

Medicine, Clinical Sciences, Internal Medicine +17

Hypoglycaemia and accident risk in people with type 2 diabetes mellitus treated with non‐insulin antidiabetes drugs

James Signorovitch, Dendy Macaulay, Markus K. Diener et al. · Diabetes Obesity and Metabolism · 2012 · 121 citations · Full text

Medicine, Internal Medicine, Clinical Epidemiology +10

Risk of developing colorectal cancer and benign colorectal neoplasm in patients with chronic constipation

A. Guérin, Reema Mody, Beverly Fok et al. · Alimentary Pharmacology & Therapeutics · 2014 · 117 citations

Medicine, Biostatistics, Oncology +15

Pediatric gastroesophageal reflux disease and acid-related conditions: trends in incidence of diagnosis and acid suppression therapy

Suzanne Nelson, Smita Kothari, E.Q. Wu et al. · Journal of Medical Economics · 2009 · 77 citations

Medicine, Pediatrics, Pharmacotherapy +15

Relative and attributable diabetes risk associated with hyperuricemia in US veterans with gout

Eswar Krishnan, Kasem S. Akhras, Hari M. Sharma et al. · QJM · 2013 · 60 citations · Full text

Medicine, Endocrinology, Internal Medicine +13